Tuesday , September 27 2022

Pancreatic cancer still more deadly – 16/11/2018



On the occasion of the World Day Against Pancreatic Cancer, held on November 15, the European paper points out that mortality rates of this type of cancer increased by 5% between 1990 and 2016. of the largest increase among the five most wanted tumors. Question: lack of funds dedicated to research.

Every year, pancreatic cancer in France affects 11,600 people and these numbers increase. It is often discovered late in the absence of specific clinical signs, unfortunately an aggressive cancer that can become, according to estimates, 2e the cause of cancer deaths by 2030

European work under guidanceUnited European Gastroenterology (a group of European companies dealing with digestive health) confirms this information. Pancreatic cancer has the lowest survival rates of all cancers in Europe. Every year, responsible for more than 95 000 deaths in the EU, the median survival rate for diagnosis is only 4.6 months. Therefore, the mortality rate increased by 5% between 1990 and 2016!

The problem, according to experts, " Pancreatic cancer research accounts for only 2% of the money spent on cancer research in Europe. In order to establish earlier diagnoses and improve treatments, now we need to undertake more basic research. " Scientists also urge the European Union to take the path of financing.

Microbot track

Researchers explain that research can quickly deliver good results. After forty years of limited progress in the study of pancreatic cancer, they say that new treatment options will finally be on the horizon, focusing on the pancreatic microbiota. In fact, the microbiological population of carcinogenic pancreatic is about 1000 times greater than that of non-carcinogenic pancreatic and research has shown that the removal of bacteria from the intestine and pancreas slows down the growth of the cancer and "reprograms" the immune cells to cancer cells.

Source link